BIOMAT Database Logo BIOMAT Database Logo

Acute safety and effects on mucociliary clearance of aerosolized uridine 5'-triphosphate +/- amiloride in normal human adults. 1996

K N Olivier, and W D Bennett, and K W Hohneker, and K L Zeman, and L J Edwards, and R C Boucher, and M R Knowles
Department of Medicine, University of North Carolina, Chapel Hill 27599-7020, USA.

Impaired mucociliary clearance contributes to the pathophysiology of several airways diseases including cystic fibrosis, asthma, and chronic bronchitis. Extracellular triphosphate nucleotides (adenosine 5'-triphosphate [ATP], uridine 5'-triphosphate [UTP]) activate several components of the mucociliary escalator, suggesting they may have potential as therapeutic agents for airways diseases. We conducted initial (Phase I) studies of acute safety and efficacy of aerosolized UTP alone and in combination with aerosolized amiloride, the sodium channel blocker, in normal human volunteers. Safety was assessed by measurement of pulmonary function. Neither UTP alone nor in combination with amiloride caused any clinically significant adverse effects on airway mechanics, (subdivisions of) lung volumes, or gas exchange. Acute efficacy of UTP and amiloride alone and in combination, was assessed by measuring changes in the clearance of inhaled radiolabeled particles. A 2.5-fold increase in mucociliary clearance was seen in response to UTP alone and in combination with amiloride. We conclude that aerosolized UTP +/- amiloride clearly enhances mucociliary clearance without acute adverse effects in normal adults, and may have therapeutic potential to enhance airways clearance in diseases characterized by retained airways secretions.

UI MeSH Term Description Entries
D008297 Male Males
D008450 Maximal Midexpiratory Flow Rate Measurement of rate of airflow over the middle half of a FORCED VITAL CAPACITY determination (from the 25 percent level to the 75 percent level). Common abbreviations are MMFR and FEF 25%-75%. Forced Expiratory Flow 025-075 Percent,FEF 25-75 Percent,Flow Rate, Maximal Midexpiratory,MMFR,25-75 Percent, FEF,25-75 Percents, FEF,FEF 25 75 Percent,FEF 25-75 Percents,Forced Expiratory Flow 025 075 Percent,Percent, FEF 25-75,Percents, FEF 25-75
D009079 Mucociliary Clearance A non-specific host defense mechanism that removes MUCUS and other material from the LUNGS by ciliary and secretory activity of the tracheobronchial submucosal glands. It is measured in vivo as mucus transfer, ciliary beat frequency, and clearance of radioactive tracers. Mucociliary Transport,Clearance, Mucociliary,Clearances, Mucociliary,Mucociliary Clearances,Mucociliary Transports,Transport, Mucociliary,Transports, Mucociliary
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D000584 Amiloride A pyrazine compound inhibiting SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with DIURETICS to spare POTASSIUM loss. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p705) Amidal,Amiduret Trom,Amiloberag,Amiloride Hydrochloride,Amiloride Hydrochloride, Anhydrous,Kaluril,Midamor,Midoride,Modamide,Anhydrous Amiloride Hydrochloride,Hydrochloride, Amiloride,Hydrochloride, Anhydrous Amiloride,Trom, Amiduret
D014544 Uridine Triphosphate Uridine 5'-(tetrahydrogen triphosphate). A uracil nucleotide containing three phosphate groups esterified to the sugar moiety. UTP,Magnesium UTP,Magnesium Uridine Triphosphate,Mg-UTP,Mg UTP,Triphosphate, Magnesium Uridine,Triphosphate, Uridine,UTP, Magnesium
D014797 Vital Capacity The volume of air that is exhaled by a maximal expiration following a maximal inspiration. Forced Vital Capacity,Capacities, Forced Vital,Capacities, Vital,Capacity, Forced Vital,Capacity, Vital,Forced Vital Capacities,Vital Capacities,Vital Capacities, Forced,Vital Capacity, Forced

Related Publications

K N Olivier, and W D Bennett, and K W Hohneker, and K L Zeman, and L J Edwards, and R C Boucher, and M R Knowles
Effect of aerosolized uridine 5'-triphosphate on mucociliary clearance in mild chronic bronchitis.
July 2001, American journal of respiratory and critical care medicine,
K N Olivier, and W D Bennett, and K W Hohneker, and K L Zeman, and L J Edwards, and R C Boucher, and M R Knowles
Effect of aerosolized uridine-5'-triphosphate on airway clearance with cough in patients with primary ciliary dyskinesia.
July 1999, American journal of respiratory and critical care medicine,
K N Olivier, and W D Bennett, and K W Hohneker, and K L Zeman, and L J Edwards, and R C Boucher, and M R Knowles
Ionic interaction of amiloride and uridine 5'-triphosphate in nebulizer solutions.
September 2004, Journal of pharmaceutical sciences,
K N Olivier, and W D Bennett, and K W Hohneker, and K L Zeman, and L J Edwards, and R C Boucher, and M R Knowles
Deposition, clearance, and effects of aerosolized amiloride in sheep airways.
November 1986, The American review of respiratory disease,
K N Olivier, and W D Bennett, and K W Hohneker, and K L Zeman, and L J Edwards, and R C Boucher, and M R Knowles
Increasing concentration of inhaled saline with or without amiloride: effect on mucociliary clearance in normal subjects.
January 2003, American journal of respiratory and critical care medicine,
K N Olivier, and W D Bennett, and K W Hohneker, and K L Zeman, and L J Edwards, and R C Boucher, and M R Knowles
Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects.
August 1993, Thorax,
K N Olivier, and W D Bennett, and K W Hohneker, and K L Zeman, and L J Edwards, and R C Boucher, and M R Knowles
Uridine 5'-triphosphate stimulates alveolar fluid clearance in the isolated rat lungs.
August 2004, Journal of pharmacological sciences,
K N Olivier, and W D Bennett, and K W Hohneker, and K L Zeman, and L J Edwards, and R C Boucher, and M R Knowles
Validity and safety of sputum induction by inhaled uridine 5'-triphosphate.
August 2001, American journal of respiratory and critical care medicine,
K N Olivier, and W D Bennett, and K W Hohneker, and K L Zeman, and L J Edwards, and R C Boucher, and M R Knowles
Acute exposure to acid fog. Effects on mucociliary clearance.
May 1993, The American review of respiratory disease,
K N Olivier, and W D Bennett, and K W Hohneker, and K L Zeman, and L J Edwards, and R C Boucher, and M R Knowles
Comparative study of cardioprotective effects of uridine-5'-monophosphate and uridine-5'-triphosphate during the early periods of acute myocardial ischemia.
September 2007, Bulletin of experimental biology and medicine,
Copied contents to your clipboard!